Although these mice demonstrated significantly lower BMMNC count compared to controls, primary YCU-AML1 mice developed marked splenomegaly (mean 671 mg, p < 0.0001; control 98.67 mg) (Fig. 3C and D). Here, RUNX1 is linked to Splenomegaly.